Leveraging AI for Drug Discovery and Investment Strategies in the Pharmaceutical Industry

In this talk, Mr. Badwan will discuss using artificial intelligence (AI) to predict FDA drug approval likelihood and inform investment decisions in the pharmaceutical industry. Bara has developed AI models that generate efficacy and toxicity prediction streamlining the drug discovery process and establishing a Probability of Technical and Regulatory Success (PTRS).

Additionally, Bara utilizes the predicted PTRS to guide investment strategies, optimizing resource allocation and minimizing risk. This approach supports the development of promising drug candidates and fosters industry growth.

The talk will provide insights into the future of AI in consulting and its potential to transform various aspects of the industry. Attendees will gain an understanding of the implications of AI-driven predictions and investment strategies, and how to adapt their practices accordingly.